Dietrich John Pauls's Net Worth

$96.6 Thousand

Estimate Recalculated Feb 7, 2024 04:04PM EST

Who is Dietrich John Pauls?

Dietrich John Pauls does not have any significant net worth to report based on the numbers we have. This is based on reported shares in DiaMedica Therapeutics Inc..

SEC CIK

Dietrich John Pauls's CIK is 0001760123

Past Insider Trading and Trends

2019 was Dietrich John Pauls's most active year for acquiring shares with 2 total transactions. Dietrich John Pauls's most active month to acquire stocks was the month of May. 2023 saw Dietrich John Pauls paying a total of $49,997.17 for 193,787 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DiaMedica Therapeutics Inc. (DMAC) Snapshot price: $3.05

President and CEO

Dietrich John Pauls owns 68,591 units of Voting Common Shares, no par value per share which is worth $209,202.55. From 2018 to 2023 Dietrich John Pauls acquired a total of 43,787 shares in DiaMedica Therapeutics Inc. at a cost of $112,574.07.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+22.91%
12.79K
$3.91
$49,997.17
68.59K
Jun 23
Form 4
—
0
—
—
0
Jun 1
Form 4
+55.86%
20K
$1.21
$24,200.00
55.8K
Nov 16
Form 4
—
0
—
—
0
Jun 1
Form 4
+16.23%
5K
$3.14
$15,700.00
35.8K
Aug 16
Form 4
—
0
—
—
0
Jul 28
Form 4
—
0
—
—
0
Jun 1
Form 4
+3.36%
1K
$2.68
$2,676.90
30.8K
Aug 16
Form 4
—
0
—
—
0
Jun 24
Form 4
+20.16%
5K
$4.00
$20,000.00
29.8K
Dec 11
Form 3
—
0
—
—
0
No matching records found